From The Army Commander To The CDMO Corner Office

What does it really take to be a successful CDMO? According to GRAM CEO Denis Johnson, it comes down to more than capacity, technology, or facilities it’s about execution. In his recent Molecule to Market podcast, Denis shares the experiences that shaped his career and leadership philosophy, from his time in the U.S. Army to decades in pharmaceutical and biologics manufacturing.
In the episode, Denis discusses:
- Why “operations is the product” in the CDMO industry
- The difference between manufacturing capacity and true capability
- Why people, experience, and operational discipline matter
- The value of taking on complex manufacturing challenges
- Where he sees sterile manufacturing and the CDMO industry heading next
For anyone involved in pharmaceutical manufacturing, CMC, outsourcing, operations, or CDMO strategy, this conversation offers valuable insight into what it takes to move medicines from development to successful commercial manufacturing.